BioPlus Acquisition Corp.
BIOSDelisted Oct 6, 2023- Industry
- Electromedical & Electrotherapeutic Apparatus
- SEC CIK
- 0001856653
BioPlus Acquisition Corp. was delisted on Oct 6, 2023; its insiders filed their last Form 4 on Jun 12, 2023; 30 institutions reported holding it in 13F filings for Q3 2023, worth $135.2M in total; no superinvestor held it.
Key figures
- Insider buys
- 0
- Open market, last 90 days
- Insider sells
- 0
- Open market, last 90 days
- 13F holders
- 30
- Q3 2023, −2 vs. previous quarter
- 13F value
- $135.2M
- Reported value at the end of Q3 2023
- Superinvestors holding
- 0
- At the end of Q3 2023
Superinvestors holding BIOS, Q3 2023
No superinvestor reported holding BIOS at the end of Q3 2023.
Latest insider trades
Open-market purchases and sales by BioPlus Acquisition Corp. insiders from Form 4, newest first.
No open-market purchases or sales by BioPlus Acquisition Corp. insiders are on file.
Top 10 13F holders, Q3 2023
The largest institutional positions in BioPlus Acquisition Corp. at the end of Q3 2023; share changes are against Q2 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Westchester Capital Management, LLC | 1,390,000 | $15.1M | 0.52% | 00.0% | Unchanged |
| Berkley W R Corp | 1,119,638 | $12.1M | 0.79% | +522,007+87.3% | Added |
| Vivaldi Asset Management, LLC | 1,106,378 | $12.0M | 0.66% | 00.0% | Unchanged |
| Linden Advisors LP | 1,000,000 | $10.8M | 0.11% | 00.0% | Unchanged |
| Radcliffe Capital Management, L.P. | 718,701 | $7.79M | 0.97% | −460.0% | Reduced |
| Cowen and Company, LLC | 679,393 | $7.36M | 0.52% | +679,393 | New |
| Mizuho Securities USA LLC | 674,829 | $7.27M | 0.22% | −339,505−33.5% | Reduced |
| Wolverine Asset Management LLC | 520,910 | $5.65M | 0.10% | +36,583+7.6% | Added |
| CNH Partners LLC | 482,993 | $5.23M | 0.24% | 00.0% | Unchanged |
| UBS Oconnor LLC | 453,158 | $4.91M | 0.09% | 00.0% | Unchanged |